Peter Wong, MD
Ophthalmology · Rockville Centre, NYNPI 1215931670
Payments from drug & device makers
Across 271 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$5K
- AbbVie$2K
- Merz North America, Inc.$479
- ANI Pharmaceuticals, Inc.$369
- Biotissue Holdings Inc.$227
- Mallinckrodt Hospital Products Inc.$204
- plus $752 from 11 others
What the payments were for
- Speaking & faculty fees$3,00034%
- Food & beverage$5,74166%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 117 | $5,014 |
| AbbVie(2 entities) | 83 | $1,697 |
| Merz North America, Inc. | 6 | $479 |
| ANI Pharmaceuticals, Inc. | 16 | $369 |
| Biotissue Holdings Inc. | 7 | $227 |
| Mallinckrodt Hospital Products Inc. | 10 | $204 |
| Novartis | 3 | $163 |
| Galderma Laboratories, L.p. | 8 | $147 |
| Sun Pharmaceutical Industries Inc. | 4 | $99 |
| Tarsus Pharmaceuticals, Inc. | 3 | $69 |
| Alimera Sciences, Inc. | 3 | $64 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $40 |
| Bausch & Lomb Americas Inc. | 2 | $40 |
| Eyepoint US, Inc. | 2 | $39 |
| Genentech USA, Inc. | 2 | $38 |
| Mallinckrodt Enterprises LLC | 2 | $37 |
| Akorn Operating Company LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,741 in reported general payments places this provider in the 85th percentile of 1,587 ophthalmology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AzasiteAzithromycin | 58 | $21,893 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 197 | $8,344 |
| ErythromycinErythromycin Base | 736 | $7,715 |
| Bepotastine Besilate | 14 | $3,422 |
| Doxycycline Hyclate | 126 | $1,815 |
| Bacitracin | 12 | $984 |
| Tobramycin | 128 | $716 |
| Prednisolone Acetate | 20 | $580 |
| Methylprednisolone | 65 | $466 |
| Tramadol Hcl | 337 | $424 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 22 | $238 |
| Ofloxacin | 27 | $221 |
| Cephalexin | 55 | $214 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 68 | $165 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Rockville Centre
- Glenn StollerRockville Centre$2.1M
- Douglas JabsNew York$24.3M
- David RubaltelliBrooklyn$8.9M
- Philip FerroneGreat Neck$5.8M
- Eric DonnenfeldGarden City$2.6M
- Nathan RadcliffeNew York$2.4M
- Richard SpaideNew York$1.7M
- Paul HartmanRochester$1.6M
- Jason SlakterNew York$1.2M
- David ChuNew York$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.